News Sentiment

6660 sentiment intelligence

AIM Vaccine Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed

Weighted score 59 Balanced news tone 7 relevant articles

Exchange HKG Hong Kong

Sector Healthcare Market context

Industry Biotechnology Read-through group

Latest close 1.50 Week of 10 Jul 2026

Weighted tone 59/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 7

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-10.2% over one week, -23.5% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

AIM's Serum-Free Iterative Rabies Vaccine Receives Acceptance for Market Registration; Institutions Predict Significant Valuation Recovery Potential for the Company

Market Reaction

Price moving ahead of tone

68/100 confidence

Primary event Market update 78/100 classification

One-week reaction -10.2% Price reacting lower

Trend fit Trend inactive -23.5% over four weeks

Fair value -81.9% Below fair value

Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance

Positive 3

Neutral 4

Negative 0

Relevance

Why the article matched

Direct first

Direct company coverage 7

Industry context 0

Sector context 0

Sources

Coverage mix

Publishers

Macau Business 5

BioWorld News 1

hkex.com.hk 1

Event Lens

What the news is about

Classified themes

Market update 5

Regulatory and legal 1

Earnings 1

Sentiment Trail

Score over time

50 baseline

Above 50 Neutral zone Below 50

News Tape